Revelation Biosciences (REVB) Share-based Compensation (2021 - 2026)
Revelation Biosciences' Share-based Compensation was $401,417 in Q2 2026, compared with $873.00 a year earlier and down 14.8% from the prior quarter.
Powered by 
Analysis
Revelation Biosciences (REVB) Share-based Compensation (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Revelation Biosciences' Share-based Compensation was $1.24 million through Jun 30, 2026, up 278.0% year-over-year; for FY2025, it came in at $595,368, up 252.6% from FY2024.
- Share-based Compensation shows a four-year compound annual growth rate of 6.0% (FY2021 to FY2025).
- In earlier years, Share-based Compensation was $168,850 in FY2024 (+8.4%), $155,721 in FY2023 (-48.3%), $301,116 in FY2022 (-36.1%) and $470,878 in FY2021.
- Quarterly Share-based Compensation has moved between $873.00 (Q2 2025) and $470,997 (Q1 2026) over five years.
- Compared with a year earlier, Share-based Compensation was higher in four of the last seven quarters, with growth averaging 149.8%.
- The best year-over-year quarter for Share-based Compensation over five years was Q1 2025 (growth of 596.3%); the worst was Q2 2025 (a decline of 97.3%).
- Per Business Quant data, REVB's Share-based Compensation in the three quarters before Q2 2026 was $470,997 (Q1 2026), $370,166 (Q4 2025) and $874.00 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Revelation Biosciences | 3.36 Mn | -45.66 Mn | - | 401,417.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 401,417.00 |
| Mar 31, 2026 | 470,997.00 |
| Dec 31, 2025 | 370,166.00 |
| Sep 30, 2025 | 874.00 |
| Jun 30, 2025 | 873.00 |
| Mar 31, 2025 | 223,455.00 |
| Dec 31, 2024 | 72,566.00 |
| Sep 30, 2024 | 32,095.00 |
| Jun 30, 2024 | 32,095.00 |
| Mar 31, 2024 | 32,094.00 |
| Dec 31, 2023 | 32,095.00 |
| Sep 30, 2023 | 32,096.00 |
| Jun 30, 2023 | 59,435.00 |
| Mar 31, 2023 | 32,095.00 |
| Dec 31, 2022 | 32,361.00 |
| Sep 30, 2022 | 40,675.00 |
| Jun 30, 2022 | 90,188.00 |
| Mar 31, 2022 | 137,892.00 |
| Dec 31, 2021 | 105,912.00 |
| Sep 30, 2021 | 131,320.00 |
API Access
Revelation Biosciences Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=REVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "REVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=REVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();